16/12/2025
CTAD 2025: Advancing Alzheimer's Research
On 29th November, Jacqui Kerr, NDN Network Manager, and Catriona McNeill, NDN Lead Nurse, represented the Neuroprogressive & Dementia Network at the Clinical Trials in Alzheimer's Disease (CTAD) 2025 conference in San Diego.
The conference brought together researchers, clinicians, and individuals with lived experience to discuss the latest advances in Alzheimer's disease research, including:
• Blood-based biomarkers to enable earlier diagnosis and support precision medicine
• Emerging therapies, including anti-amyloid treatments
• Diversity and inclusion in clinical trials, ensuring research reaches all communities
A key takeaway from the conference was the invaluable contribution of research participants worldwide. Their dedication allows researchers to develop new treatments, improve care, and better understand Alzheimer's disease.
To learn more about our work or how to participate in clinical research, please visit:
https://www.nhsresearchscotland.org.uk/research-areas/dementia-and-neurodegenerative-disease